CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2025	Sep. 30, 2024
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income	$ 274,591	$ 317,555
Adjustments to reconcile net income to net cash provided by operating activities:
Deferred taxes	(9,409)	17,465
Depreciation and amortization	135,441	106,905
Stock-based compensation	141,582	134,855
Non-cash operating lease cost	29,504	28,603
Impairment loss on Assets held for sale	23,142	0
Impairment of equity investment	85	115
Other non-cash operating activities	29,349	6,931
Changes in assets and liabilities, net of effects of acquisitions:
Accounts receivable	(117,709)	(135,239)
Inventories	3,055	32,304
Prepaid expenses and other assets	(4,053)	(26,283)
Accounts payable	6,729	(13,283)
Accrued and other long-term liabilities	(67,730)	47,618
Long-term income tax payable	14,130	(5,186)
Deferred revenues	(88,661)	(60,207)
Net cash provided by operating activities	370,046	452,153
CASH FLOWS FROM INVESTING ACTIVITIES:
Acquisitions, net of cash acquired	0	(77,075)
Purchase of property, plant and equipment	(66,529)	(92,619)
Proceeds from maturities of marketable securities	0	25,660
Proceeds from sales of marketable securities	0	18,193
Purchase of equity investments	(10,000)	(75,390)
Other investing activities	0	235
Net cash used in investing activities	(76,529)	(200,996)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from issuance of common stock	21,749	25,281
Common stock repurchases, net of excise tax	(368,691)	(150,012)
Payroll taxes paid upon the vesting of equity awards	(20,232)	(27,972)
Net cash used in financing activities	(367,174)	(152,703)
Effect of foreign exchange rate changes on cash, cash equivalents, and restricted cash	34,502	6,008
Net (decrease) increase in cash, cash equivalents, and restricted cash	(39,155)	104,462
Cash, cash equivalents and restricted cash at beginning of the period	1,044,963	938,519
Cash, cash equivalents and restricted cash at end of the period	$ 1,005,808	$ 1,042,981